Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat.
Pilocarpine administered in doses of 1.25-10.0 mg/kg (IP) produced a variety of mouth movements in the rat. The most frequent of these movements was a chewing behaviour, which increased up to a mean frequency of over 40 per min at the highest doses. Tongue protrusion and gaping also showed dose-dependent increases. Yawning tended to increase in some doses, though these increases were not significant, and yawning was relatively infrequent. Pre-treatment with scopolamine reduced these responses, while pre-treatment with methyl scopolamine did not. Injections of oxotremorine or arecoline, but not carbachol, produced dose-related increases in mouth movements similar to those produced by pilocarpine. These results suggest that mouth movements in the rat are caused by stimulation of central muscarinic receptors. This may prove to be an important behavioural sign of central cholinomimetic activity.
D000818:Animals; D001115:Arecoline / Q000494:pharmacology; D001921:Brain / Q000187:drug effects*; D002217:Carbachol / Q000494:pharmacology; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D009055:Mouth; D010095:Oxotremorine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010862:Pilocarpine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012601:Scopolamine / Q000494:pharmacology
D010277:Parasympathomimetics; D010862:Pilocarpine; D001115:Arecoline; D010095:Oxotremorine; D002217:Carbachol; D012601:Scopolamine